What is Olaparib?

Olaparib is a PARP inhibitor used to treat breast, prostate, ovarian, pancreatic, fallopian tube, or peritoneal cancer. Lynparza works by blocking a protein called PARP, which helps cancer cells repair themselves. Blocking PARP causes cancer cells to die. Lynparza may be used if the cancer has specific genetic markers, including negative BRAC1, BRCA2, HRR, and HER2, and your doctor will test for the gene. Lynparza, a tablet usually taken twice daily with or without food, was first approved by the FDA in 2014 for the treatment of advanced ovarian cancer.

Before taking the medication, Lynparza should not be used if the patient is allergic to Lynparza. To ensure that Lynparza is safe for your patients, tell your doctor if you have lung disease, breathing problems, or kidney disease. Lynparza may harm your unborn baby or cause miscarriage if the mother or father is using this medicine. If the patient is female do not use this medication if she becomes pregnant. Before starting this treatment, the patient may need to have a negative pregnancy test and use effective contraception to prevent pregnancy while taking this medication and for at least 6 months after the last dose. Ifthe patientis a male patient, please take effective birth control measures and continue to use birth control pills at least3 months after the last dose. Also, do not donate sperm within 3 months after your last dose. If a mother or father becomes pregnant while taking this medicine, tell your doctor right away. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.